PAGE 12 — ABOUT THIS REPORT
About This Report
12.1 What This Report Is
The research report on which this site is based — Unacknowledged Casualties: Quinoline Antimalarial Drug Toxicity, Domestic Violence, and Secondary Harm to Spouses and Partners of ADF East Timor Veterans — was prepared in 2026 for investigative, policy, and advocacy purposes.
It synthesises peer-reviewed scientific literature, regulatory agency documentation, Australian Senate inquiry submissions, coronial inquest records, veteran advocacy evidence, domestic violence research, neuropsychiatric literature, and neurotoxicology sources. It incorporates the findings of the Royal Commission into Defence and Veteran Suicide (Final Report, September 2024) and the Australian Government response (December 2024).
The report was prepared with a clear methodological commitment: to distinguish throughout between established medical consensus, official ADF and DVA positions, advocacy claims, and areas of ongoing scientific uncertainty. No medical diagnoses are made. Causation is not asserted beyond what the peer-reviewed literature supports. All claims are attributed.
12.2 What This Report Is Not
This report is not a medical document and does not provide medical advice. It is not a legal document and does not provide legal advice. It does not make diagnoses of any individual. It does not assert that mefloquine or tafenoquine caused any specific act of violence or any specific family outcome.
It is an evidence synthesis prepared to make a complex, under-documented issue accessible to journalists, policymakers, affected families, and the general public — and to support the case for the institutional responses described in the recommendations section.
12.3 Source Transparency
Two figures are central to the Australian evidence base drawn on throughout this report.
Major Stuart McCarthy of the Quinoline Veterans and Families Association (QVFA) prepared Senate Submission 94, which is the primary source for much of the Australian-specific factual and institutional detail cited throughout this site. Major McCarthy is himself an affected veteran and a sustained advocate for quinoline veterans and their families. His submission is detailed, internally consistent, and supported by publicly available documentation. Readers should be aware of his standing as an advocate as well as a witness when weighing his evidence.
Professor Jane Quinn of Charles Sturt University prepared Senate Submission 73. She is a neurotoxicologist whose peer-reviewed work on quinoline toxicity is cited in the independent scientific literature. She is also the widow of a British Army officer who died by suicide in 2006 following a documented severe adverse reaction to mefloquine. Her scientific expertise and her personal history are both relevant to her evidence; this dual standing is disclosed here so that readers can weigh her contributions with that context in view.
The underlying neurotoxicology that both draw upon is independently established in the international peer-reviewed literature. The advocacy submissions and the peer-reviewed Australian papers are not wholly independent of one another — a relationship this site acknowledges wherever it is relevant.
12.4 The Four Evidential Registers
This site uses four evidential registers throughout its pages, identified at the foot of each section.
Established fact refers to findings confirmed by peer-reviewed science, regulatory agency determinations, or official parliamentary, coronial, or governmental records. These are the most robust claims on this site and can be verified against primary sources.
Plausible mechanism refers to a biological or clinical pathway that is consistent with the scientific literature and provides a credible explanation, but has not been demonstrated by a direct study in the specific ADF veteran population. Plausible mechanisms are presented as serious hypotheses warranting investigation — not as proven findings.
Documented case evidence refers to cases or patterns recorded in advocacy submissions, parliamentary testimony, or media records. These are accurately represented as sourced, but have not been independently verified by this site. Readers relying on this material for legal or formal purposes should consult primary sources.
Area of uncertainty identifies questions that the current evidence does not resolve. These are stated honestly rather than minimised. The central uncertainty of this site — the absence of a direct study demonstrating the rate of domestic violence in the ADF quinoline cohort — is the most significant, and it is identified as a research priority throughout.
12.5 The Causation Framing
This report does not claim that quinoline toxicity is the sole cause of domestic violence in affected ADF families, nor that it is necessarily the primary cause.
The most defensible reading of the evidence is that the harm experienced by spouses is overdetermined — that quinoline-induced neurological injury, combat-related trauma, the documented culture of militarised masculinity within the ADF, and the failure of the institutional response each contribute, and that they compound one another.
Notably, the strongest peer-reviewed Australian study of intimate partner violence in ADF families (Pollard and Ferguson, 2020) attributes the problem to cultural and structural factors and does not address drug toxicity at all. This site argues that quinoline neurotoxicity is a serious, under-investigated contributor that the responsible institutions have failed to examine — not that it displaces the other causes.
Where the evidence permits only an inference rather than a demonstrated causal chain, this is stated explicitly throughout.
12.6 The Framing on Blame
This report consistently frames harm to the veteran without attribution of moral blame.
Neurologically injured individuals are not morally responsible for pharmacologically induced behavioural changes they did not choose and were not warned about. The harm documented throughout this site is systemic in origin. It begins with the decision to administer potent neurotoxic drugs to service personnel without adequate consent, monitoring, or follow-up care.
Acknowledging the harm to partners does not require, and this site does not engage in, characterising affected veterans as perpetrators in the ordinary moral sense. Both things are true: serious harm has been caused to partners and families, and the causal chain for that harm runs through institutional decisions, not through the character of the individuals who were drugged.
12.7 Download the Full Report
The complete research report — Unacknowledged Casualties: Quinoline Antimalarial Drug Toxicity, Domestic Violence, and Secondary Harm to Spouses and Partners of ADF East Timor Veterans — is available for download.
[Download the report (PDF)]
12.8 Key Sources
Australian Senate and Parliamentary Sources
McCarthy, S. (QVFA). Submission 94: Use of the Quinoline Anti-Malarial Drugs Mefloquine and Tafenoquine in the Australian Defence Force. Foreign Affairs, Defence and Trade References Committee, 2018.
Quinn, Dr Jane C. Submission 73: Mefloquine toxicity: implications for serving personnel and veterans of the Australian Defence Force. Senate Foreign Affairs, Defence and Trade References Committee Inquiry into the Mental Health of ADF Serving Personnel.
Royal Commission into Defence and Veteran Suicide. Final Report, Volume 4, Chapter 22. September 2024.
Australian Government Response to the Royal Commission into Defence and Veteran Suicide. December 2024.
Regulatory Agency Documents
US FDA. Drug Safety Communication: FDA approves label changes for antimalarial drug mefloquine hydrochloride due to risk of serious psychiatric and nerve side effects. 2013.
US FDA. Product label information — mefloquine hydrochloride. 2013.
Therapeutic Goods Administration (TGA). Database of Adverse Event Notifications (DAEN): mefloquine and tafenoquine entries.
Australian mefloquine product data sheet (F.H. La Roche / Roche Products Pty Ltd, PIL.4158, 2014).
UK MHRA. Drug Safety Update: Mefloquine — strengthened warnings on neuropsychiatric side effects.
Peer-Reviewed and Medical Literature
Ritchie, E.C., Block, J., and Nevin, R.L. (2013). Psychiatric side effects of mefloquine: applications to forensic psychiatry. Journal of the American Academy of Psychiatry and the Law, 41(2), 224–235.
Nevin, R.L. (2014). Idiosyncratic quinoline central nervous system toxicity: historical insights into the chronic neurological sequelae of mefloquine. International Journal for Parasitology: Drugs and Drug Resistance, 4(2), 118–125.
Nevin, R.L., and Ritchie, E.C. (2016). The mefloquine intoxication syndrome. In Post-Traumatic Stress Disorder and Related Diseases in Combat Veterans. Springer International.
Quinn, J.C. (2015). Complex membrane channel blockade: A unifying hypothesis for the prodromal and acute neuropsychiatric sequelae resulting from exposure to the antimalarial drug mefloquine. Journal of Parasitology Research.
McCarthy, S. (2015). Malaria prevention, mefloquine neurotoxicity, neuropsychiatric illness, and risk-benefit analysis in the Australian Defence Force. Journal of Parasitology Research.
Dow, G., et al. (2006). Mefloquine induces dose-related neurological effects in a rat model. Antimicrobial Agents and Chemotherapy, 50(3), 1045–1053.
Domestic Violence and Military Research
Epidemiological reviews of intimate partner violence in returning veteran populations. Epidemiological Reviews, Oxford University Press, 2015.
Research on post-deployment reintegration, substance abuse, and family violence in combat veterans. ScienceDirect, multiple sources.
US Army and CDC review of Fort Bragg homicides (2002); subsequent forensic psychiatric commentary by Nevin and Ritchie.
12.9 Contact
This site was prepared as part of an investigative research project examining the ADF antimalarial drug trials of 1998–2002. It is intended for research, advocacy, and policy purposes.
[Contact form / email address]